Chronic Kidney Disease(CKD)NCT06674031
Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients
An observational study of Chronic Kidney Disease(CKD) and Renal Transplantation, run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to assess knowledge of cardiovascular risk factors, physical activity levels, health literacy and perceptions of benefits and barriers to exercise in patients with chronic kidney disease and compare them with healthy people. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Chronic Kidney Disease(CKD), Renal Transplantation
- How many people
- 28 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 6 Nov 2024to May 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Chronic kidney disease patients and healthy individuals will be included in the study.
Who may be able to join
- Patients with chronic kidney disease
- Being aged 18-65
- Voluntary participation in the study
Who cannot join
- Having cognitive problems
- Being illiterate
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Hacettepe University
Ankara
Naciye Vardar-Yagli, +90 312 305 15 76 ext. 123, naciyevardar@yahoo.com
About this study
Official title: Investigation of Knowledge of Cardiovascular Risk Factors and Perception of Benefits and Barriers to Exercise in Patients with Chronic Kidney Disease
The aim of this study is to assess knowledge of cardiovascular risk factors, physical activity levels, health literacy and perceptions of benefits and barriers to exercise in patients with chronic kidney disease and compare them with healthy people.
- Conditions
- Chronic Kidney Disease(CKD), Renal Transplantation
- Medical subject headings
- Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Chronic kidney disease | Not described | |
| Healthy individuals | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge of cardiovascular risk factors
It will be evaluated Cardiovascular Diseases Risk Factors Knowledge Level scale. The maximum score that can be obtained from the 28-question scale is 28. Higher scores indicate better knowledge of cardiovascular disease.
Measured: 10 minutes
Exercise benefits/barriers
This will be evaluated using exercise benefits/barriers scale. Possible scores on the benefits scale ranged from 29 to 116 points. Higher scores indicate greater benefits.The range of possible scores on the barriers scale was 14 to 54 points. Higher scores indicate fewer perceived barriers.
Measured: 10 minutes
Physical activity
Physical activity level will be evaluated using International Physical Activity Questionnaire-Short form. This questionnaire lists activities and asks for estimates of the duration and frequency of each activity in the past week. The durations are multiplied by the MET value for each activity and the results for all items are summed to give an overall physical activity score.
Measured: 5 minutes
Secondary outcomes (1)
Health literacy
It will be evaluated with the Health Literacy Scale-Short Form. The score ranges from 0 to 50, with higher scores indicating better health literacy.
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2024
- Study start6 Nov 2024
- Primary completionFeb 2025 (estimated)
- Study completionMay 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Kidney Disease(CKD)Studies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 28 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Firat, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06674031
- Sponsor's protocol ID
- SBA 23/275
- Status last verified
- Nov 2024
- First submitted
- 3 Nov 2024
- Last updated
- 27 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Knowledge of Cardiovascular Risk Factors and Perception of Benefits and Barriers to Exercise in Patients with Chronic Kidney Disease
- ClinicalTrials.gov ID
- NCT06674031
- Acronym / sponsor ID
- SBA 23/275
- Conditions
- Chronic Kidney Disease(CKD), Renal Transplantation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 28 participants (estimated)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 6 Nov 2024 (actual)
- Primary completion
- Feb 2025 (estimated)
- Study completion
- May 2025 (estimated)
- First posted
- 5 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to assess knowledge of cardiovascular risk factors, physical activity levels, health literacy and perceptions of benefits and barriers to exercise in patients with chronic kidney disease and compare them with healthy people.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Chronic kidney disease | – | – |
| Healthy individuals | – | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Chronic kidney disease patients and healthy individuals will be included in the study.
Key inclusion criteria (3 listed)
- Patients with chronic kidney disease
- Being aged 18-65
- Voluntary participation in the study
Key exclusion criteria (2 listed)
- Having cognitive problems
- Being illiterate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Knowledge of cardiovascular risk factors
Time frame: 10 minutes
It will be evaluated Cardiovascular Diseases Risk Factors Knowledge Level scale. The maximum score that can be obtained from the 28-question scale is 28. Higher scores indicate better knowledge of cardiovascular disease.
Exercise benefits/barriers
Time frame: 10 minutes
This will be evaluated using exercise benefits/barriers scale. Possible scores on the benefits scale ranged from 29 to 116 points. Higher scores indicate greater benefits.The range of possible scores on the barriers scale was 14 to 54 points. Higher scores indicate fewer perceived barriers.
Physical activity
Time frame: 5 minutes
Physical activity level will be evaluated using International Physical Activity Questionnaire-Short form. This questionnaire lists activities and asks for estimates of the duration and frequency of each activity in the past week. The durations are multiplied by the MET value for each activity and the results for all items are summed to give an overall physical activity score.
1 secondary outcome
Health literacy
Time frame: 5 minutes
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Nov 2024.
Related trials for Chronic Kidney Disease(CKD)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruiting
An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care
Chronic Kidney Diseases
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
RecruitingObservational study
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Chronic Kidney Disease, Type 2 Diabetes Mellitus
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Chronic Kidney Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Kidney Disease(CKD) and Renal Transplantation, run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Merve Firat (+90 850 441 02 44, mervefirat@ahievran.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge of cardiovascular risk factors (time frame: 10 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2024.